Combinatorial therapy is a safe and durable treatment option in ALK-rearranged non-small cell lung cancer with an acquired MET exon 14 skipping mutation mediated resistance to alectinib: a case report
-
Published:2023-12
Issue:12
Volume:12
Page:2558-2564
-
ISSN:2218-6751
-
Container-title:Translational Lung Cancer Research
-
language:
-
Short-container-title:Transl Lung Cancer Res
Author:
Jang Charley,Sabari Joshua
Publisher
AME Publishing Company
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Alectinib;Reactions Weekly;2024-02-17